U.S. Markets open in 5 hrs 19 mins

PowerShares Dynamic Retail ETF (PMR)


NYSEArca - NYSEArca Delayed Price. Currency in USD
Add to watchlist
34.42-0.10 (-0.29%)
At close: 1:41PM EDT
People also watch
PEJPSJPBSPICPUI
Full screen
Previous Close34.52
Open34.53
Bid0.00 x
Ask0.00 x
Day's Range34.41 - 34.53
52 Week Range33.55 - 38.86
Volume859
Avg. Volume2,715
Net Assets14.09M
NAV35.22
PE Ratio (TTM)N/A
Yield0.91%
YTD Return-2.67%
Beta (3y)0.55
Expense Ratio (net)0.63%
Inception Date2005-10-26
Trade prices are not sourced from all markets
  • PR Newswire8 days ago

    FDA Chooses Zepsyre™ (PM1183) from PharmaMar to Explore Potential Development for Pediatric Cancers

    The Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) of the FDA, has invited PharmaMar to participate in this ODAC, giving a presentation to provide background information on Zepsyre™, positive clinical data obtained from phases I and II, in which a good tolerance and a good safety profile were observed, and to assess the potential role of this drug in pediatric cancers and hematological disorders. Zepsyre™ (PM1183), PharmaMar´s investigational drug, is one of the three products chosen by ODAC.

  • Benzinga9 days ago

    Winners And Losers From Amazon's Purchase Of Whole Foods

    When the dust finally settled on Amazon.com, Inc. (NASDAQ: AMZN )’s historic $13.7 billion buyout bid for Whole Foods Market, Inc. (NASDAQ: WFM ) on Friday, Whole Foods stock was up 29.1 percent on the ...

  • PR Newswire12 days ago

    PharmaMar Will Commercialize PM1183 With the Trade Name of Zepsyre™

    MADRID , June 16, 2017 /PRNewswire/ -- PharmaMar ( MCE: PHM ) has announced that PM1183 (lurbinectedin), its third molecule of marine origin and analogue of Yondelis ® , will receive the trade name of ...